Absci has built a leading generative AI Drug Creation platform for therapeutic antibodies and we’re excited to bring this expertise into animal health,” said Sean McClain, Founder and CEO of Absci.
Absci (ABSI) and Invetx announced a strategic partnership to harness Absci’s AI Drug Creation models to create an innovative Half-Life ...
The "Animal Feed Additives Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's ...
Midland Animal Services welcomes Dr. Amy Lowe as their new full-time veterinarian, addressing a long-standing need amid ...
And will beekeepers care enough to do it? Those are the questions Annette Kleiser has been wrestling since founding Dalan Animal Health in 2018. Five years after launching the startup, the ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
G technology boosts the capabilities of robotics, facilitating seamless communication and real-time control, crucial for ...
Maggot Therapy Gains Popularity in Emerging Economies as Affordable Solution for Wound Care Global Maggot Debridement Market ...
"With climate change and evolving animal agriculture practices, the need for public health practitioners that have veterinary knowledge is high. As a veterinarian treating animals, I can both see and ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...